Skip to content
Back to VIR

Vir Biotechnology, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
34
Purchases
0
Sales
34
Purchase value
$0.00
Sale value
$8.18M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Vanina de VerneuilEVP, General Counsel, Corp Sec
4Rule 10b5-1 plan disclosed
Filed Nov 4, 2026Period of report Nov 2, 20260001628280-26-070025
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 3, 2026
Common StockF32,407$11.10$26.72K110,193Direct
SaleNov 2, 2026
Common StockF1F21,343$11.334$15.22K112,600Direct
Filing footnotes · 3
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2Includes 961 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.
  3. F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026.
Open on SEC EDGAR
Janet NapolitanoDirector
4Rule 10b5-1 plan disclosed
Filed Jun 2, 2026Period of report Jun 1, 20260001628280-26-039943
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF13,200$9.45$30.24K21,216Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025.
Open on SEC EDGAR
Brent SabatiniSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Jun 2, 2026Period of report Jun 1, 20260001628280-26-039938
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F2379$9.45$3.58K61,902Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
  2. F2Includes 379 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed May 4, 2026Period of report May 1, 20260001628280-26-029640
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF1F222,000$10.0466$221.03K1,078,391Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Marianne De BackerDirector · President and CEO
4Rule 10b5-1 plan disclosed
Filed Apr 7, 2026Period of report Apr 6, 20260001628280-26-024098
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 6, 2026
Common StockF172,559$9.156$664.35K948,145Direct
Filing footnotes · 2
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Apr 2, 2026Period of report Apr 1, 20260001628280-26-022971
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF1F222,000$9.0735$199.62K1,100,391Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.87 to $9.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Brent SabatiniSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Mar 24, 2026Period of report Mar 23, 20260001628280-26-020823
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 23, 2026
Common StockF17,711$9.12$70.32K61,902Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 2, 20260001628280-26-013630
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF1F221,800$9.5039$207.19K1,122,591Direct
SaleMar 2, 2026
Common StockF1F3200$9.98$2.00K1,122,391Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.97 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Mark EisnerEVP and Chief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012394
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 25, 2026
Common StockF21,889$9.82$18.55K154,024Direct
SaleFeb 24, 2026
Common StockF11,616$9.5326$15.40K155,913Direct
Filing footnotes · 2
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.
Open on SEC EDGAR
Vanina de VerneuilEVP, General Counsel, Corp Sec
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012393
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 25, 2026
Common StockF213,700$9.82$134.53K112,982Direct
SaleFeb 24, 2026
Common StockF13,117$9.5326$29.71K126,682Direct
Filing footnotes · 2
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2025.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012397
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF1F242,177$9.7521$411.31K1,144,591Direct
SaleFeb 24, 2026
Common StockF1200$10.26$2.05K1,144,391Direct
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.23 to $10.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. F3Shares vested and became exercisable in 36 equal monthly installments from October 5, 2017.
Open on SEC EDGAR
Brent SabatiniSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012396
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF11,430$9.5326$13.63K69,613Direct
Filing footnotes · 1
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open on SEC EDGAR
Jason O'ByrneEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012395
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF11,634$9.5326$15.58K162,615Direct
Filing footnotes · 1
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
Open on SEC EDGAR
Marianne De BackerDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 26, 2026Period of report Feb 24, 20260001628280-26-012390
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF114,762$9.5326$140.72K1,020,704Direct
Filing footnotes · 2
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees.
Open on SEC EDGAR
Brent SabatiniSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 22, 20260001628280-26-011331
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF21,829$7.4528$13.63K71,043Direct
Filing footnotes · 3
  1. F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  2. F2Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.v
  3. F325% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Jason O'ByrneEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 22, 20260001628280-26-011330
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF32,089$7.4528$15.57K164,249Direct
Filing footnotes · 4
  1. F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  2. F2Includes 637 shares of common stock acquired by the Reporting Person on November 28, 2025, pursuant to an employee stock purchase program.
  3. F3Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.
  4. F425% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Mark EisnerEVP and Chief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 22, 20260001628280-26-011329
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF22,089$7.4528$15.57K157,529Direct
Filing footnotes · 3
  1. F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  2. F2Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.
  3. F325% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Vanina de VerneuilEVP, General Counsel, Corp Sec
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 22, 20260001628280-26-011328
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF34,445$7.4528$33.13K129,799Direct
Filing footnotes · 4
  1. F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  2. F2Includes 1,034 shares of common stock acquired by the Reporting Person on November 28, 2025 pursuant to an employee stock purchase program.
  3. F3Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.
  4. F425% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Marianne De BackerDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 22, 20260001628280-26-011327
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF219,039$7.4528$141.89K1,035,466Direct
Filing footnotes · 4
  1. F1Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
  2. F2Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.
  3. F3The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees.
  4. F425% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.
Open on SEC EDGAR
Brent SabatiniSVP, Chief Accounting Officer
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 13, 20260001628280-26-008984
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common StockF1F21,530$7.79$11.92K47,872Direct
Filing footnotes · 2
  1. F1Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.
  2. F2Includes 2,290 and 485 shares of common stock acquired by the Reporting Person on May 30, 2025 and November 28, 2025, respectively, pursuant to an employee stock purchase program.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Feb 3, 2026Period of report Feb 2, 20260001628280-26-004866
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF1F222,000$7.7123$169.67K1,144,391Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to $7.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Jan 5, 2026Period of report Jan 2, 20260001628280-26-000320
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 2, 2026
Common StockF1F222,000$5.9265$130.38K1,166,391Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.84 to $6.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
SB Investment Advisers (UK) Ltd10% owner
Softbank Vision Fund (AIV M1) L.P.10% owner
SVF Endurance (Cayman) Ltd10% owner
4Rule 10b5-1 plan disclosed
Filed Dec 3, 2025Period of report Dec 1, 20250001493152-25-025970
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF1F2F3191,854$5.9826$1.15M13,728,924IndirectSee footnote
Filing footnotes · 3
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2794 to $5.855. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.
Open on SEC EDGAR
Vicki L SatoDirector
4Rule 10b5-1 plan disclosed
Filed Dec 2, 2025Period of report Dec 1, 20250001628280-25-054884
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF1F222,000$6.0032$132.07K1,188,391Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.87 to $6.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Open on SEC EDGAR
SB Investment Advisers (UK) Ltd10% owner
Softbank Vision Fund (AIV M1) L.P.10% owner
SVF Endurance (Cayman) Ltd10% owner
4Rule 10b5-1 plan disclosed
Filed Dec 1, 2025Period of report Nov 26, 20250001493152-25-025571
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 28, 2025
Common StockF1F4F361,493$6.44$396.01K13,920,778IndirectSee footnote
SaleNov 26, 2025
Common StockF1F2F3127,938$6.391$817.65K13,982,271IndirectSee footnote
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2498 to $6.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.3396 to $6.5398. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
SB Investment Advisers (UK) Ltd10% owner
Softbank Vision Fund (AIV M1) L.P.10% owner
SVF Endurance (Cayman) Ltd10% owner
4Rule 10b5-1 plan disclosed
Filed Nov 26, 2025Period of report Nov 24, 20250001493152-25-025161
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common StockF1F4F3235,971$6.38$1.51M14,110,209IndirectSee footnote
SaleNov 24, 2025
Common StockF1F2F3227,803$6.1491$1.40M14,346,180IndirectSee footnote
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.6094. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Jason O'ByrneEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2025Period of report Nov 17, 20250001628280-25-052841
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 17, 2025
Common StockF1F26,799$5.557$37.78K110,701Direct
Filing footnotes · 2
  1. F1Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
  2. F2Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.